Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OMX Stockholm PI | OMXSPI | Jan 2, 2025 | 966.06 | +1.20 |
OMX Stockholm Real Estate PI | SX35PI | Jan 2, 2025 | 3 422.89 | +1.00 |
OMX Stockholm Retail PI | SX4040PI | Jan 2, 2025 | 1 010.23 | -0.03 |
OMX Stockholm Small Cap GI | OMXSSCGI | Jan 2, 2025 | 555.45 | +2.62 |
OMX Stockholm Small Cap PI | OMXSSCPI | Jan 2, 2025 | 1 098.42 | +2.62 |
OMX Stockholm Technology PI | SX10PI | Jan 2, 2025 | 1 841.87 | +1.14 |
OMX Stockholm Telecommunications PI | SX15PI | Jan 2, 2025 | 855.26 | +1.32 |
OMX Stockholm Travel & Leisure PI | SX4050PI | Jan 2, 2025 | 6 619.60 | +1.68 |
OMX Stockholm Utilities PI | SX65PI | Jan 2, 2025 | 485.48 | +3.54 |
OMXS SC 30 ESG Responsible GI | OMXSS30ESGGI | Jan 2, 2025 | 904.86 | +1.68 |
Oncopeptides | ONCO | Jan 2, 2025 | 1.58 | +1.29 |
OncoZenge | ONCOZ | Jan 2, 2025 | 3.54 | -5.60 |
Oneflow | ONEF | Jan 2, 2025 | 35.00 | -4.11 |
Online Brands Nordic | OBAB | Jan 2, 2025 | 15.60 | -3.41 |
oodash Group | OODA | Jan 2, 2025 | 43.60 | -4.80 |
Opter | OPTER | Jan 2, 2025 | 125.00 | +3.31 |
OptiCept Technologies | OPTI | Jan 2, 2025 | 4.88 | -1.71 |
Orexo | ORX | Jan 2, 2025 | 18.24 | +4.23 |
OrganoClick | ORGC | Jan 2, 2025 | 2.93 | +2.09 |
Orron Energy AB | ORRON | Jan 2, 2025 | 7.51 | +5.62 |
Ortivus A | ORTIA | Jan 2, 2025 | 3.36 | 0.00 |
Ortivus B | ORTIB | Jan 2, 2025 | 1.45 | +3.96 |
Ortoma B | ORTB | Jan 2, 2025 | 9.14 | -1.51 |
OssDsign | OSSD | Jan 2, 2025 | 10.34 | +4.87 |
OurLiving AB | OURLIV | Jan 2, 2025 | 0.23 | -4.10 |
Ovzon | OVZON | Jan 2, 2025 | 19.10 | +11.57 |
OXE Marine | OXE | Jan 2, 2025 | 0.35 | +2.65 |
Pandox B | PNDXB | Jan 2, 2025 | 193.60 | +0.94 |
Paradox Interactive | PDX | Jan 2, 2025 | 211.60 | +3.02 |
Paratus Energy Services | PLSVO | 0.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.